The TNFR1 Antagonist Atrosimab Is Therapeutic in Mouse Models of Acute and Chronic Inflammation

Therapeutics that block tumor necrosis factor (TNF), and thus activation of TNF receptor 1 (TNFR1) and TNFR2, are clinically used to treat inflammatory diseases such as rheumatoid arthritis, inflammatory bowel disease and psoriasis. However, TNFR1 and TNFR2 work antithetically to balance immune resp...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Front Immunol
Glavni autori: Richter, Fabian, Williams, Sarah K., John, Katharina, Huber, Carina, Vaslin, Camille, Zanker, Henri, Fairless, Richard, Pichi, Kira, Marhenke, Silke, Vogel, Arndt, Dhaen, Marie-Ann, Herrmann, Stefanie, Herrmann, Andreas, Pfizenmaier, Klaus, Bantel, Heike, Diem, Ricarda, Kontermann, Roland E., Fischer, Roman
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2021
Teme:
Immunology
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8294390/
https://ncbi.nlm.nih.gov/pubmed/34305946
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2021.705485
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items